Overview of IBA’s Share Buyback Program
Ion Beam Applications SA (IBA), an esteemed leader in particle accelerator technology, recently unveiled its strategic share buyback initiative that seeks to enhance shareholder value and reinforce management incentives. The program, announced earlier this year, is poised to repurchase up to 650,000 ordinary shares in accordance with the Belgian Code on Companies and Associations.
Recent Share Acquisitions
From May 13 to May 19, 2025, IBA executed a series of transactions under this program, successfully repurchasing a total of 26,500 shares on Euronext Brussels. This buyback activity reflects IBA's commitment to its long-term growth and alignment of interests with its valued employees, particularly those participating in the company’s incentive plans.
Detailed Breakdown of Transactions
The share buyback transactions conducted during this period highlight significant attention to market conditions and pricing. Here’s a closer look at the shares acquired:
Daily Purchase Summary
The following shares were repurchased:
- On May 14, 2025, IBA acquired 3,000 shares at an average price of €11.58.
- Following closely, on May 15, 2025, the company purchased 7,000 shares at €11.41 each.
- Another 7,000 shares were bought on May 16 at an average price of €11.38.
- Finally, on May 19, 2025, IBA purchased 9,500 shares at €11.20.
In total, these purchases accumulated to a substantial investment of approximately €300,726.65. The total number of shares repurchased under the program has now reached 582,849.
Current Treasury Shares Status
As IBA continues its buyback strategy, the current tally of treasury shares highlights the company’s robust share structure. After the recent transactions, IBA’s treasury shares, encompassing shares held directly and through its subsidiary IBA Investments SRL, are outlined below:
Treasury Shares Insights
The breakdown reveals a total of:
- 51,973 shares held by IBA Investments SRL with voting rights amounting to 103,946.
- 896,428 shares directly held by IBA SA with voting rights tallying to 962,851.
This aggregates to a total of 948,401 treasury shares, suggesting a 3.13% stake relative to the overall issued shares of 30,282,218, with voting rights equivalent to 40,514,366.
About IBA
Founded in Louvain-la-Neuve, Belgium, IBA stands at the forefront of proton therapy, a pioneering approach in radiation treatment. The company’s dedication to innovation has made it a vital player in industries ranging from industrial sterilization to radiopharmaceuticals and dosimetry. With a workforce of approximately 2,100 employees globally, IBA is not only a leader in technology but also a certified B Corporation, upholding the highest standards of social and environmental performance.
Contact Information
For inquiries, please reach out to:
IBA
Thomas Pevenage
Investor Relations
investorrelations@iba-group.com
Frequently Asked Questions
What is the purpose of IBA's share buyback program?
The program aims to enhance shareholder value and fulfill long-term incentive commitments.
How many shares has IBA repurchased so far?
As of now, IBA has repurchased a total of 582,849 shares under this buyback initiative.
What are the average prices of the recent shares bought?
The average prices for the most recent shares ranged between €11.20 and €11.58.
What is IBA known for?
IBA is renowned for its advances in proton therapy and its commitment to social responsibility as a certified B Corporation.
How can IBA shareholders stay informed?
Shareholders can follow updates through press releases or contact investor relations for detailed inquiries.
